Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1967 1
1968 2
1971 3
1972 4
1973 2
1974 6
1975 2
1976 2
1977 1
1978 5
1979 3
1980 1
1981 1
1982 6
1983 5
1984 1
1985 2
1986 4
1987 1
1988 1
1990 2
1991 1
1992 3
1993 1
1995 2
1996 1
1997 2
1998 3
1999 7
2000 2
2001 5
2002 3
2003 16
2004 6
2005 13
2006 8
2007 16
2008 14
2009 26
2010 22
2011 18
2012 17
2013 24
2014 14
2015 19
2016 33
2017 21
2018 23
2019 26
2020 1
Text availability
Article attribute
Article type
Publication date

Search Results

359 results
Results by year
Filters applied: . Clear all
Page 1
Interleukin-17 inhibition: role in psoriasis and inflammatory bowel disease.
Hohenberger M, Cardwell LA, Oussedik E, Feldman SR. Hohenberger M, et al. J Dermatolog Treat. 2018 Feb;29(1):13-18. doi: 10.1080/09546634.2017.1329511. Epub 2017 May 31. J Dermatolog Treat. 2018. PMID: 28521565 Review.
Ustekinumab and Anti-Interleukin-23 Agents in Crohn's Disease.
Deepak P, Sandborn WJ. Deepak P, et al. Gastroenterol Clin North Am. 2017 Sep;46(3):603-626. doi: 10.1016/j.gtc.2017.05.013. Gastroenterol Clin North Am. 2017. PMID: 28838418 Review.
Anti-TNF Therapy.
Udalova I, Monaco C, Nanchahal J, Feldmann M. Udalova I, et al. Microbiol Spectr. 2016 Aug;4(4). doi: 10.1128/microbiolspec.MCHD-0022-2015. Microbiol Spectr. 2016. PMID: 27726761 Review.
Distinct expression of interleukin (IL)-36α, β and γ, their antagonist IL-36Ra and IL-38 in psoriasis, rheumatoid arthritis and Crohn's disease.
Boutet MA, Bart G, Penhoat M, Amiaud J, Brulin B, Charrier C, Morel F, Lecron JC, Rolli-Derkinderen M, Bourreille A, Vigne S, Gabay C, Palmer G, Le Goff B, Blanchard F. Boutet MA, et al. Clin Exp Immunol. 2016 May;184(2):159-73. doi: 10.1111/cei.12761. Epub 2016 Feb 22. Clin Exp Immunol. 2016. PMID: 26701127 Free PMC article.
Impact of a Patient Support Program on Patient Adherence to Adalimumab and Direct Medical Costs in Crohn's Disease, Ulcerative Colitis, Rheumatoid Arthritis, Psoriasis, Psoriatic Arthritis, and Ankylosing Spondylitis.
Rubin DT, Mittal M, Davis M, Johnson S, Chao J, Skup M. Rubin DT, et al. J Manag Care Spec Pharm. 2017 Aug;23(8):859-867. doi: 10.18553/jmcp.2017.16272. Epub 2017 Mar 15. J Manag Care Spec Pharm. 2017. PMID: 28737994 Free article.
Immunogenicity of Biologics in Chronic Inflammatory Diseases: A Systematic Review.
Strand V, Balsa A, Al-Saleh J, Barile-Fabris L, Horiuchi T, Takeuchi T, Lula S, Hawes C, Kola B, Marshall L. Strand V, et al. BioDrugs. 2017 Aug;31(4):299-316. doi: 10.1007/s40259-017-0231-8. BioDrugs. 2017. PMID: 28612180 Free PMC article. Review.
Genome-wide Pleiotropy Between Parkinson Disease and Autoimmune Diseases.
Witoelar A, Jansen IE, Wang Y, Desikan RS, Gibbs JR, Blauwendraat C, Thompson WK, Hernandez DG, Djurovic S, Schork AJ, Bettella F, Ellinghaus D, Franke A, Lie BA, McEvoy LK, Karlsen TH, Lesage S, Morris HR, Brice A, Wood NW, Heutink P, Hardy J, Singleton AB, Dale AM, Gasser T, Andreassen OA, Sharma M; International Parkinson’s Disease Genomics Consortium (IPDGC), North American Brain Expression Consortium (NABEC), and United Kingdom Brain Expression Consortium (UKBEC) Investigators. Witoelar A, et al. JAMA Neurol. 2017 Jul 1;74(7):780-792. doi: 10.1001/jamaneurol.2017.0469. JAMA Neurol. 2017. PMID: 28586827 Free PMC article.
359 results
Jump to page
Feedback